Skip to main content
OpenTrials
Completed

NCT Number: NCT05189249

Determinant of Repeat Revascularization After Percutaneous Coronary Intervention

To determine factors associated with repeat revascularization among adults aged 25 years and above within 5 years of first Percutaneous Coronary Intervention (PCI) at a tertiary care hospital.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Aga Khan University

Karachi, Sindh, 74800, Pakistan

About this study

Matched case-control study design was employed to determine the association between re-peat revascularization and its determinants in patients within 5 years of undergoing index PCI. The case was defined as a patient who had undergone repeat revascularization within 5 years of undergoing index PCI. Control was defined as a patient who had not undergone repeat revascularization within 5 years of undergoing index PCI.

The retrospective study was carried out with the approval of the Ethical Review Committee of the tertiary care hospital where the study was carried out. A waiver of informed consent was granted as this was a retrospective study and all patients were discharged from the hospital.

A minimum of 120 cases with matched 240 controls were required in 1:2 case to control ratio. This sample size was essential to achieve the power of 80% for an anticipated matched odds ratio of 2 with the hypothesized correlation of 0.2 using a two-sided hypothesis test with a significance level of 0.05.

The outcome of the study was the Repeat revascularization status. There are different types of repeat revascularization according to the site and lesion to which intervention has been provided. Any type of repeat revascularization was considered and enrolled as a case in this study5.

Covariates included in the study were divided into patient characteristics (gender, age, health coverage, BMI, smoking status), comorbidity status (Hypertension, Diabetes Mellitus, Hyperlipidaemia, valvular disease), clinical characteristics (Creatinine level, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Cholesterol level, other technical factors related to the index PCI) and medication status (Beta-blocker, ACE Inhibitor, Statin).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Cases:

  • Aged 25 years and older
  • Undergone repeat revascularization within 5 years of undergoing index PCI (from 2011 to 2017).

Exclusion criteria

for Cases:

  • If suffering from any hypercoagulable disorder
  • Revascularization procedure was per-formed outside the study setting
  • Staged PCI within 3 weeks or planned PCI within 6 months of Index PCI.

Inclusion criteria

for Controls:

  • Patients aged 25 years and older
  • Undergone PCI once from the year 2011 to 2017.

Exclusion criteria

for Controls:

  • If suffering from any hypercoagulable disorder.

Treatment and study plan

No intervention performed

Other

No intervention performed. Participants were enrolled retrospectively and medical records were accessed for data.

Primary outcomes

  1. Factors associated with repeat revascularization

    Time frame: January 2018 to December 2018

    Identify factors that are associated with repeat coronary intervention in the form of PCI or CABG once patient has been discharged after index PCI and during follow-up years (excluding staged PCI planned within three weeks of index PCI).

Sponsors and collaborators

Lead sponsor

Aga Khan University

Other

Registry information

Official study title

Determinant of Repeat Revascularization Within 5 Years of Percutaneous Coronary Intervention at a Tertiary Care Hospital, Karachi: A Matched Case-Control Study

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 12, 2022
Registry last updated
Jul 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.